Pharmacology and Therapeutic Potential of the 5-HT7 Receptor

被引：35

作者：

Blattner, Kevin M. ^{[1
]}

Canney, Daniel J. ^{[1
]}

Pippin, Douglas A. ^{[2
]}

Blass, Benjamin E. ^{[1
]}

机构：

[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Moulder Ctr Drug Discovery Res, 3307 North Broad St, Philadelphia, PA 19140 USA

[2] Praeventix LLC, 665 Stockton Dr,Suite 200H, Exton, PA 19341 USA

来源：

ACS CHEMICAL NEUROSCIENCE | 2019年 / 10卷 / 01期

关键词：

Serotonin receptor; serotonin (5-HT); G-protein-coupled receptor (GPCR); 5-HT7; receptor; agonist; antagonist; PROTEIN-KINASE-A; EXTRACELLULAR-REGULATED KINASE; ANTEROVENTRAL PREOPTIC REGION; ANTIDEPRESSANT-LIKE BEHAVIOR; MULTIOBJECTIVE BASED DESIGN; PHRENIC MOTOR FACILITATION; DEPRESSIVE-LIKE BEHAVIORS; GENOME-WIDE ASSOCIATION; BETA-CASEIN EXPRESSION; EYE-MOVEMENT SLEEP;

D O I：

10.1021/acschemneuro.8b00283

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

It is well-documented that serotonin (5-HT) exerts its pharmacological effects through a series of 5-HT receptors. The most recently identified member of this family, 5-HT7, was first identified in 1993. Over the course of the last 25 years, this receptor has been the subject of intense investigation, and it has been demonstrated that 5-HT7 plays an important role in a wide range of pharmacological processes. As a result of these findings, modulation of 5-HT7 activity has been the focus of numerous drug discovery and development programs. This review provides an overview of the roles of 5-HT7 in normal physiology and the therapeutic potential of this interesting drug target.

引用

页码：89 / 119

页数：61

共 50 条

[21] Tetrahydrobenzindoles as selective 5-HT7 receptor antagonists
Lloyd, AW
DRUG DISCOVERY TODAY, 1999, 4 (06) : 290 - 290
[22] Tetrahydrobenzindoles:: Selective antagonists of the 5-HT7 receptor
Kikuchi, C
Nagaso, H
Hiranuma, T
Koyama, M
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) : 533 - 535
[23] 5-HT7 receptor signaling: in gut disorders
Kim, Janice J.
Khan, Waliul I.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2014, 8
[24] The cloned human 5-HT7 receptor splice variants:: a comparative characterization of their pharmacology, function and distribution
Krobert, KA
Bach, T
Syversveen, T
Kvingedal, AM
Levy, FO
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (06) : 620 - 632
[25] The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution
Kurt A. Krobert
Trond Bach
Trygve Syversveen
Ane Kvingedal
Finn Levy
Naunyn-Schmiedeberg's Archives of Pharmacology, 2001, 363 : 620 - 632
[26] Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task
Perez-García, GS
Meneses, A
BEHAVIOURAL BRAIN RESEARCH, 2005, 163 (01) : 136 - 140
[27] Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy
Okubo, Ruri
Hasegawa, Toshiki
Fukuyama, Kouji
Shiroyama, Takashi
Okada, Motohiro
FRONTIERS IN PSYCHIATRY, 2021, 12
[28] SB-258741:: A 5-HT7 receptor antagonist of potential clinical interest
Pouzet, B
CNS DRUG REVIEWS, 2002, 8 (01): : 90 - 100
[29] 5-HT1A and 5-HT7 receptor expression in the mammalian retina
Pootanakit, K
Brunken, WJ
BRAIN RESEARCH, 2000, 875 (1-2) : 152 - 156
[30] Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update
Modica, Maria N.
Lacivita, Enza
Intagliata, Sebastiano
Salerno, Loredana
Romeo, Giuseppe
Pittala, Valeria
Leopoldo, Marcello
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8475 - 8503

← 1 2 3 4 5 →